Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 3.86
-3.62 %
$ 512 M
Market Cap
-32.17
P/E
INCOME STATEMENT
433 M
REVENUE
12.5 M
OPERATING INCOME
4.94 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Organogenesis Holdings Inc.
| Revenue | 433 M |
| Cost Of Revenue | 123 M |
| Gross Profit | 310 M |
| Operating Expenses | 314 M |
| Operating Income | 12.5 M |
| Other Expenses | 7.58 M |
| Net Income | 4.94 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 433.1 | 450.9 | 468.1 | 338.3 | 261.0 | 193.4 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 123.3 | 105.0 | 114.2 | 87.3 | 75.9 | 68.8 | 4.6 | 0.2 |
| Gross Profit | 309.8 | 345.9 | 353.9 | 251.0 | 185.0 | 124.6 | (4.6) | (0.2) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 314.1 | 323.6 | 280.9 | 223.6 | 214.5 | 172.7 | 4.6 | 0.2 |
| Selling, General and Administrative Expenses | 269.8 | 283.8 | 250.2 | 203.5 | 199.7 | 162.0 | 4.6 | 0.2 |
| Research and Development Expenses | 44.4 | 39.8 | 30.7 | 20.1 | 14.8 | 10.7 | 0 | 0 |
| Operating Income | 12.5 | 22.3 | 72.9 | 27.4 | (29.5) | (51.6) | (4.6) | 0.2 |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 2.2 | 2.0 | 7.2 | 11.3 | 9.0 | 10.9 | 8.0 | 5.6 |
| Total Other Income | (2.1) | (2.0) | (9.1) | (8.9) | (10.8) | (13.2) | 3.4 | 8.6 |
| Pre-Tax Income | 10.4 | 20.3 | 63.8 | 18.5 | (40.3) | (64.7) | (2.1) | (0.2) |
| NET INCOME | ||||||||
| Tax Provision | 5.4 | 4.8 | (31.1) | 0.5 | 0.1 | 84 K | 52.5 K | (0.4) |
| Net Income | 4.9 | 15.5 | 94.2 | 17.2 | (40.5) | (64.8) | (2.1) | (0.2) |
| EPS | 0.0377 | 0.12 | 0.73 | 0.16 | 0.44 | 0.94 | 0.0328 | 0.0033 |